Abdominal fluid reveals rare immune cells that may limit attacks on tumors
In a study published in Science Immunology, researchers used malignant ascites—fluid that accumulates in the abdomen of some patients when cancer metastasizes to the abdominal cavity—to uncover immune programs associated with metastatic disease, including a rare population of RORC-expressing dendritic cells not previously linked to human cancer.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Novel radiotherapy may save increasingly many rectal cancer patients from surgery and a stoma
United Kingdom
-
Maternal vaccines protect babies from serious infections, but unequal access limits benefits across Europe
United Kingdom
-
Scientists identify the neuroblastoma cells that signal poor outcomes
United Kingdom
-
'Immune fog' may flag lung cancer risk years before tumor develops
United Kingdom
-
Peanut consumption affects the lipid profile circulating in the blood
United Kingdom
-
Electrical ablation boosts CAR-NK cell therapy against liver cancer, offering new strategy for refractory solid tumors
United Kingdom
-
A self-disinfecting fabric eliminates bacteria, fungi and viruses in hospital settings
United Kingdom
-
Food order can shift short-term blood sugar and insulin responses after a meal
United Kingdom